Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Receivables - Other: 2010

  • Catalyst Pharmaceuticals' Receivables - Other was N/A to $134,025 in Q4 2010 from the same period last year, while for Dec 2010 it was $134,025, marking a year-over-year change of. This contributed to the annual value of $134,025 for FY2010, which is N/A change from last year.
  • Catalyst Pharmaceuticals' Receivables - Other amounted to $134,025 in Q4 2010.
  • Catalyst Pharmaceuticals' 5-year Receivables - Other high stood at $134,025 for Q4 2010, and its period low was $134,025 during Q4 2010.
  • For the 1-year period, Catalyst Pharmaceuticals' Receivables - Other averaged around $134,025, with its median value being $134,025 (2010).